APA (7th ed.) Citation

Kudo, M. Immune Checkpoint Inhibitor plus Anti-VEGF/TKI Combined with Transarterial Chemoembolization in Locally Advanced Nonmetastatic Hepatocellular Carcinoma: Real-World Treatment Strategy Based on Phase 3 Clinical Trial Results. Karger Publishers.

Chicago Style (17th ed.) Citation

Kudo, Masatoshi. Immune Checkpoint Inhibitor Plus Anti-VEGF/TKI Combined with Transarterial Chemoembolization in Locally Advanced Nonmetastatic Hepatocellular Carcinoma: Real-World Treatment Strategy Based on Phase 3 Clinical Trial Results. Karger Publishers.

MLA (9th ed.) Citation

Kudo, Masatoshi. Immune Checkpoint Inhibitor Plus Anti-VEGF/TKI Combined with Transarterial Chemoembolization in Locally Advanced Nonmetastatic Hepatocellular Carcinoma: Real-World Treatment Strategy Based on Phase 3 Clinical Trial Results. Karger Publishers.